chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blood clots; She's been bedridden now for 3 days; she's in bed she can't even standup long enough to brush her teeth cause she got nerve pain in her legs that she got a blood clot; she's in bed she can't even standup long enough to brush her teeth cause she got nerve pain in her legs that she got a blood clot; had to quit her jobs its awful; she's really depressed; This is a spontaneous report from a contactable consumer. This contactable consumer reported for a female patient of an unknown age received second dose of BNT162B2 (Solution for injection, batch/ lot number: unspecified), via an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (Solution for injection, batch/ lot number: unspecified), via an unspecified date as historical vaccine as single dose for COVID-19 immunisation. Caller stated "It is in regard to my older sister and she had some it's been 3 months since she got her 2nd vaccination. She's been bedridden now for 3 days, 3 days after she got her second Pfizer shot. Like I said after 3 months she's in bed she can't even stand up long enough to brush her teeth cause she got nerve pain in her legs that she got a blood clot from like I said it happened 3 days after she got her second shot. I am only trying to give the doctors something to go on because the pain she's in I can't even believe her doctors are letting her go for 3 months without being able to move. Her and her husband had to quit her jobs its awful and I'm worried about her both physically and mentally she's really depressed." The outcome of the adverse events was unknown.  The lot number for the vaccine, was not provided and will be requested during follow up.
swollen lymph nodes under right arm  week after first injection did not get better  second injection was given in left arm a week after swollen lymph nodes underarm left arm now two weeks out have swollen lymph nodes everywhere neck behind ears back groin inner thighs
The patient was actually diagnosed with Covid-19 later the same day; The patient was actually diagnosed with Covid-19 later the same day; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative.  A 75-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 75 years for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Oct2022, outcome "unknown" and all described as "The patient was actually diagnosed with Covid-19 later the same day". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Oct2022) Positive, notes: The patient was actually diagnosed with Covid-19 later the same day.  Clinical course: On 01Oct2022 after approximately 4 hours after vaccination with Covid-19 Bivalent Vaccine, patient experienced fever, dyspnea, and myalgias. The patient was diagnosed with Covid-19 later the same day. Optional Information was none. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on limited information in the case , a possible causal association between  all  the reported events Drug ineffective , Covid 19 and the suspect drug cannot be excluded.
Sore on left side of tongue; This is a spontaneous report from a contactable healthcare professional, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the right arm on 26Apr2021 at 16:00 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. Medical history included heart disorder, joint/pain back and neck, hypertension (htn), hyperlipidemia, angina, diabetes, and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took (diclofenac) VOLTAREN and (topiramate) TOPAMAX; both for an unspecified indication from an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the right arm on 29Mar2021 at 16:00 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. On 24May2021 at 01:00, the patient experienced sore on the left side of the tongue. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with unspecified medication (Med). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore on left side of tongue was not recovered at the time of this report.
pt recvd vax; pt had liver function abnormality; devel flu-like illness; arthralgia; headache; ESR inc; malaise; asthenia/fatigue; fever; chills; pain, abdominal; myalgia;
I was about 9 weeks pregnant with no complications at the time of my second vaccination. Estimated  due date was 08/24/2021.  I began bleeding and cramping and having headaches approximately 10 days after my second dose. I sought medical attention and was told that my baby no longer had a heart beat and that growth (based on ultrasound) had stopped around the 9 week mark. I had medical assistance to physically miscarry the deceased fetus. I have one healthy living son (2 years,  4 months old) who was delivered without complications naturally.
This spontaneous report was received from a pharmacist referring to a female patient of unknown age. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies was not reported. The reporter stated that the patient was administered three doses of MMR II, (route of administration, lot # and expiration date were not provided). The first dose was administered on an unspecified date, when the patient was 16 months old. The second dose was administered on an unspecified date, when the patient was 18 months old. On an unspecified date in 2015, reported as "last year", when the patient was 25 years old, she was administered a booster dose of MMR II. Concomitant medication was not reported. On an unknown date, th patient had titers drawn and the titers for rubella "came back low" (viral titre decreased). At the time of reporting, the outcome of the viral titre decreased was unknown. The reporter did not assess the relatedness between viral titre decreased and MMR II. Additional information has been requested.
Swollen lymph nodes, achy joints, hot, nauseous, pain and soreness at injection site.
Patient presented with fever up into the 104 range and red dotted-like rash on her trunk, upper arms and thighs.  Contact was made via telephone with nurse at facility.  After describing the rash the nurse verbalized feeling as if the symptoms were a result of the MMR vaccine based on the description timeframe post vax that it presented.
Client began having neurologic symptoms (blurred vision, weakness) week of 11/21/05; tested to rule out stroke, multiple sclerosis; formal diagnosis of Guillan Barre Syndrome made in 1/06; client admitted to hospital for plasmaphorese in 2/06 for three days. Medical records state headache, abnormal gait. msv
Chills, nausea, feverish, body pain, tiredness. Missed one day of work, also experienced diarrhea for 6 days after
has gotten sick; Initial information received on 11-Dec-2021 regarding an unsolicited valid Social Media serious case received from a consumer/non-healthcare professional under reference number US-SA-SAC20211217000130.  This case involves a patient of (unknown demographics) who experienced gotten sick (illness), after receiving vaccines INFLUENZA VACCINE and COVID-19 VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  No other concomitant vaccines were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient received a dose of suspect COVID-19 VACCINE not produced by Sanofi Pasteur (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE and (unknown latency) following the administration of COVID-19 VACCINE. The patient was hospitalized for this event.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.; Sender's Comments: This case involves a patient of (unknown demographics) who experienced illness, after receiving vaccines INFLUENZA VACCINE produced by unknown manufacturer and COVID-19 VACCINE not produced by Sanofi Pasteur. The time to onset is not known for any event. However, patient's medical condition at time of vaccination, Lab data and other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the individual vaccines cannot be assessed.
chills and muscle aches about 16 hours after injection continued chills and myalgia along with headaches about 24 hours after injection  at 30 hours after injection symptoms  persist
Tiredness; Headache; Chills; Nausea; Feeling a general malaise; This is a spontaneous report from a contactable healthcare professional, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration  in the left arm on 12May2021 at 11:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient medical history included service connected veteran. The patient did not have allergies to medications, food, or other products. Concomitant medication included MULTIVITAMIN from an unknown date, for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration  on an unknown date as a single dose for COVID-19 immunisation. On 12May2021 at 12:00, the patient experienced tiredness, headache, chills, nausea, felt a general malaise. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events  tiredness, headache, chills, nausea, felt a general malaise was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Per patient on 10/6 experienced redness then migrated down to different parts of arm including forearm. Painful but no itching.
I had typical injection site pain, for 2 days following the shot, and was then fine. I had no other symptoms. Today, 13 days later, I developed moderate pain at the injection site, and throughout the day, have since developed a golf ball sized, hard hematoma-like mass at the site. It is sore and painful, and feels like a very tender bruise. No itching or redness is present.
Minor reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Minor reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Minor reactions). At the time of the report, VACCINATION COMPLICATION (Minor reactions) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Treatment information was not provided. Concomitant product use was not provided.
Purple tongue, Purple teeth, Ulcers on tongue,  Headache, swollen lymph node under left arm, burning rash on and off on lower back on both sides, left sharp ear pain, body aches, chills/sweats but no fevers, fatigue,   No treatment gradual resolution of sx's.
Pt flinched while administering ID which caused the vaccine to squirt out.  Pt revaccinated via subcutaneous route.
This spontaneous report as received from a medical assistant refers to 4 year old patient of unknown gender. On an unknown date in April 2014, between 12-APR-2014 and 24-APR-2014, the patient was vaccinated with a dose of VARIVAX lot # J006358, expiry 23-MAY-2015 ("VFC" stock), 0.5 ml, once, intramuscular. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX was exposed to 46F for 1 hour, at worst. There were no prior excursions. There was a site visit from local health department on an unspecified date. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a 14 to 16 year old obese male who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The physician reported that when the patient was 4 to 6 years old he developed a mild case of shingles. Unspecified medical attention was sought and the patient was treated with acyclovir ointment. Two weeks after the initial diagnosis, the patient's shingles resolved. Additional information has been requested.
Per mom, that evening developed fever. Mom had been using antipyretics, mom heard him wake in middle of nite, when mom went to get him he developed gen'l T/C seizure lasting less than a minute. Felt warm. Called 911. To ER via amb. Diagnosed with OM. Fever 104.7 Dx: febrile seizure. Improved on antipyretics. Seen 10/23 @ENT-ears nl.
Influenza vaccine unknown details of where pt received vaccine and which brand. 2 weeks after vaccine, pt developed  lightheadedness, not spinning, when walked to bathroom, then lied down and it improved.  When she tried to stand up again she could not feel her toes and was unable to balance. bending her knees made it worse.  Later her finger tips were numb. face not involved.  both toes and fingers had tingling.  She did not walk for 2 days and is unsure if legs are also weak, feels they are and feels it is more difficult to use her hands and they may be weak. She was found to have Guillan-Barre syndrome/ AIDP
Patient complained of tingling lips and tachycardia. BP 159/90 HR 105. RRT called. Patient transported to Emergency Department.
I now have constant tinnitus in my ears.  I never had anything like this before .  I suspect there are countless unreported cases like this on top of those that have been reported.  It is up to the FDA/CDC to act on this and also demand that the vaccine manufacturers (Pfizer in my case) list this as a known side-effect, and also determine what can be done to help resolve the issue!
Off feeling all day then arm began itching at the vaccine site, it was red puffy around site with a rim.
Received Varicella vaccine on 7/20/16. On 7/26/16 developed rash all over body. Seen by dermatologist who diagnosed with allergic reaction to varicella.
Initial pregnancy report received from a healthcare professional on 08 May 2013. A 37-year-old female patient, whose medical history and concomitant medications were not reported, had received a first intramuscular dose of ADACEL vaccine, (lot number: U4612AA, and site of vaccination was not reported) on 08 May 2013. The date of last menstrual period was on 24 August 2012. The patient's estimated date of delivery was reported as 31 May 2013. At the time of this report, the patient had not experienced any adverse event. The patient's health during pregnancy, specific risk factors (e.g.: alcohol, tobacco or recreational drugs) was not reported. Treatment for infertility was not reported. Documents held by sender: none.
Experienced flushing, SOB.  Taken to EMT staging, attended by EMTs.  VS 157/94, 148/82, 154/93, 160/90.  Pulse 91-99.  O2 sat 98-100%.  Had not eaten today.  Began to feel better.  Given juice and cookies.  At ~ 4:30pm symptoms resumed.  Advised transport to ED for further evaluation.  Pt agreed.  Taken to  ED by EMTs @ 5:05pm.
-Patient received undiluted Pfizer Peds 5-11 Vaccine -Patient contracted and notified and denies any s/s of adverse reactions at this time.
Dizziness; Body aches; Headache; Extreme fatigue; Nausea; Muscle pain; High fever; Chills; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (Dizziness), PYREXIA (High fever), CHILLS (Chills), PAIN (Body aches) and MYALGIA (Muscle pain) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2020, the patient experienced PYREXIA (High fever), CHILLS (Chills), MYALGIA (Muscle pain) and NAUSEA (Nausea). On 04-Jan-2021, the patient experienced FATIGUE (Extreme fatigue). On an unknown date, the patient experienced DIZZINESS (Dizziness), PAIN (Body aches) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness), PYREXIA (High fever), CHILLS (Chills), PAIN (Body aches), MYALGIA (Muscle pain), HEADACHE (Headache), FATIGUE (Extreme fatigue) and NAUSEA (Nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Symptoms of COVID-19 /COVID-19 positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Symptoms of COVID-19 /COVID-19 positive) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Sep-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Symptoms of COVID-19 /COVID-19 positive). At the time of the report, SARS-COV-2 TEST POSITIVE (Symptoms of COVID-19 /COVID-19 positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Sep-2021, SARS-CoV-2 test: positive (Positive) Tested positive on Sunday, 06/Sep/2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported Treatment medication were not reported
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment information was not provided.   This case was linked to MOD-2021-250809 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow-up received on 8-JUN-2021 updated outcome of the event and action taken.
pt recv vax 22SEP97 & 28SEP97 pt devel poss bacterial meningitis, which was felt to be life-threatening;
Moderna primary series for ages 6 years through 11 years bivalent booster dose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (Moderna primary series for ages 6 years through 11 years bivalent booster dose) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Moderna primary series for ages 6 years through 11 years bivalent booster dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Moderna primary series for ages 6 years through 11 years bivalent booster dose) and NO ADVERSE EVENT (No adverse event) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Moderna primary series for ages 6 years through 11 years bivalent booster dose). Concomitant medications were not reported. 7 adult patients received the vaccine primary series for ages 6 years through 11 years bivalent booster dose. No treatment information was provided by the reporter.